Whole-body MRI: a practical guide for imaging patients with malignant bone disease.
Loading...
Embargo End Date
Authors
Winfield, JM
Blackledge, MD
Tunariu, N
Koh, D-M
Messiou, C
Blackledge, MD
Tunariu, N
Koh, D-M
Messiou, C
Document Type
Journal Article
Date
2021-10-01
Date Accepted
2021-04-08
Abstract
Whole-body magnetic resonance imaging (MRI) is now a crucial tool for the assessment of the extent of systemic malignant bone disease and response to treatment, and forms part of national and international recommendations for imaging patients with myeloma or metastatic prostate cancer. Recent developments in scanners have enabled acquisition of good-quality whole-body MRI data within 45 minutes on modern MRI systems from all main manufacturers. This provides complimentary morphological and functional whole-body imaging; however, lack of prior experience and acquisition times required can act as a barrier to adoption in busy radiology departments. This article aims to tackle the former by reviewing the indications and providing guidance for technical delivery and clinical interpretation of whole-body MRI for patients with malignant bone disease.
Citation
Clinical radiology, 2021
Source Title
Publisher
W B SAUNDERS CO LTD
ISSN
0009-9260
eISSN
1365-229X